Eyeworld

EW IN OTHER NEWS 102 December 2017 CyPass ® Micro-Stent IMPORTANT PRODUCT INFORMATION CAUTION: FEDERAL (USA) LAW RESTRICTS THIS DEVICE TO SALE BY OR ON THE ORDER OF A PHYSICIAN. INDICATION: The CyPass ® Micro-Stent is indicated for use in conjunction with cataract surgery for the reduction of intraocular pressure (IOP) in adult patients with mild to moderate primary open-angle glaucoma (POAG). CONTRAINDICATIONS: Use of the CyPass Micro-Stent is contraindicated in the following circumstances or conditions: (1) in eyes with angle-closure glaucoma; and (2) in eyes with traumatic, malignant, uveitic, or neovascular glaucoma or discernible congenital anomalies of the anterior chamber angle. MRI INFORMATION: The CyPass Micro-Stent is magnetic resonance (MR) Safe: the implant is constructed of polyimide material, a non-conducting, non-metallic, non-magnetic polymer that poses no known hazards in all magnetic resonance imaging environments. WARNINGS: Gonioscopy should be performed prior to surgery to exclude peripheral anterior synechiae (PAS), rubeosis, and other angle abnormalities or conditions that would prohibit adequate visualization of the angle that could lead to improper placement of the stent and pose a hazard. PRECAUTIONS: The surgeon should monitor the patient postoperatively for proper maintenance of intraocular pressure. The safety and effectiveness of the CyPass Micro-Stent has not been established as an alternative to the primary treatment of glaucoma with medications, in patients 21 years or younger, in eyes with significant prior trauma, chronic inflammation, eyes with an abnormal anterior segment, eyes with chronic inflammation, eyes with glaucoma associated with vascular disorders, pseudophakic eyes with glaucoma, eyes with uveitic glaucoma, eyes with pseudoexfoliative or pigmentary glaucoma, eyes with other secondary open-angle glaucomas, eyes that have undergone prior incisional glaucoma surgery or cilioablative procedures, eyes with laser trabeculoplasty performed ≤ 3 months prior to the surgical screening visit, eyes with unmedicated IOP less than 21 mmHg or greater than 33 mmHg, eyes with medicated IOP greater than 25 mmHg, in the setting of complicated cataract surgery with iatrogenic injury to the anterior or posterior segment, and when implantation is without concomitant cataract surgery with IOL implantation for visually significant cataract. The safety and effectiveness of use of more than a single CyPass Micro-Stent has not been established. ADVERSE EVENTS: In a randomized, multicenter clinical trial comparing cataract surgery with the CyPass Micro-Stent to cataract surgery alone, the most common postoperative adverse events included: BCVA loss of 10 or more letters at 3 months after surgery (8.8% for the CyPass Micro-Stent vs. 15.3% for cataract surgery only); anterior chamber cell and flare requiring steroid treatment 30 or more days after surgery (8.6% vs. 3.8%); worsening of visual field mean deviation by 2.5 or more decibels (6.7% vs. 9.9%); IOP increase of 10 or more mmHg 30 or more days after surgery (4.3% vs. 2.3%); and corneal edema 30 or more days after surgery, or severe in nature (3.5% vs. 1.5%). AT TENTION: PLEASE REFER TO THE INSTRUCTIONS FOR A COMPLETE LIST OF CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, AND ADVERSE EVENTS. © 2017 Novartis 9/17 US-CYP-17-E-2272 As their families grow, they spend more time with their children and a little less hands-on time with the business. She noted that they are still involved in every aspect of the management of the vineyard and winery and enjoy participating in wine festivals and events at the win- ery, which helps them stay in touch with the people who are drinking their wines. There are a lot of similarities between winemaking and the precision in ophthalmology be- cause there's so much that you have to look at from the growing of the grapes to the processing to the blending and the storage that can affect the quality of the wine. "It's as meticulous as doing a great LASIK surgery," she said. There is the surgery itself and the outcome, but there is also everything that comes before it that contributes to the outcome. "They are both a lot of fun and have similarities in terms of how diligent you need to be," she said. Dr. Hoffman works at Kremer Eye Center, which has three main locations in King of Prussia, Pennsyl- vania; Cherry Hill, New Jersey; and Wilmington, Delaware. She is the medical director of both the Cherry Hill and Wilmington offices. She is a cornea specialist who focuses on refractive surgery, and has been in practice since 1995, shortly before opening the winery. "We opened the winery just after I started my oph- thalmology residency," she said. "I am fortunate to have these two very different but rewarding lives," Dr. Hoffman said, adding that when she gives lectures, she often includes slides of the winery. "It's nice to be able to talk about and share both," she said. EW Contact information Hoffman: Carol.Hoffman@kremereyecenter.com Ophthalmologist continued from page 101 Paradocx produces a total of 14 wines; from left: Barn Red, a medium-bodied, semisweet red blend, Vidal Blanc, a crisp, fruity white varietal, and Cabernet Sauvignon, a dry medium- bodied, red wine Source all: Carol Hoffman, MD

• Blank Page
• Blank Page (1)